The proteasome inhibitor carfilzomib exerts anti-inflammatory and antithrombotic effects on the endothelium-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The proteasome inhibitor carfilzomib exerts anti-inflammatory and antithrombotic effects on the endothelium

Published:2024-07 Issue:7 Volume:22 Page:1867-1879
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Hjazi Ahmed,Maroto Celia Gonzalez,Rodriguez-Gutierrez Maria Elena,Appiah Michael,Ignat Ana,Mobayen Golzar,Page Theresa,McKinnon Thomas A.J.

Funder

Imperial College Healthcare NHS Trust

Prince Sattam bin Abdulaziz University

Publisher

Elsevier BV

Reference71 articles.

1. Multiple myeloma;Kumar;Nat Rev Dis Primers,2017

2. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma;Rajkumar;Lancet Oncol,2014

3. Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma;Kristinsson;Blood,2008

4. Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis;Piedra;Br J Haematol,2022

5. Emerging immunotherapies in multiple myeloma;Shah;BMJ,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Endoplasmic Reticulum Stress‐Related Biomarkers in Coronary Artery Disease;Cardiovascular Therapeutics;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP